Kennedy Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-176,809
| Closed | -$743K | – | 710 |
|
|
2023
Q1 | $743K | Buy |
176,809
+238
| +0.1% | +$1K | 0.02% | 516 |
|
|
2022
Q4 | $1.06M | Sell |
176,571
-135
| -0.1% | -$811 | 0.03% | 488 |
|
|
2022
Q3 | $1.03M | Sell |
176,706
-323,728
| -65% | -$1.88M | 0.03% | 476 |
|
|
2022
Q2 | $2.99M | Sell |
500,434
-132,825
| -21% | -$793K | 0.08% | 369 |
|
|
2022
Q1 | $2.96M | Sell |
633,259
-95,136
| -13% | -$444K | 0.07% | 393 |
|
|
2021
Q4 | $1.81M | Buy |
728,395
+224,013
| +44% | +$555K | 0.04% | 463 |
|
|
2021
Q3 | $1.49M | Buy |
+504,382
| New | +$1.49M | 0.03% | 492 |
|
|
2020
Q4 | – | Sell |
-10,000
| Closed | -$22K | – | 726 |
|
|
2020
Q3 | $22K | Buy |
+10,000
| New | +$22K | ﹤0.01% | 646 |
|
|
2018
Q3 | – | Sell |
-394,505
| Closed | -$1.97M | – | 806 |
|
|
2018
Q2 | $1.97M | Sell |
394,505
-7,123
| -2% | -$35.5K | 0.04% | 600 |
|
|
2018
Q1 | $1.57M | Buy |
401,628
+155,439
| +63% | +$606K | 0.03% | 629 |
|
|
2017
Q4 | $660K | Buy |
+246,189
| New | +$660K | 0.01% | 697 |
|